Early life stress (ELS) is a known risk factor for suffering psychopathology in adulthood. The hypothalamic-pituitary-adrenal (HPA) axis has been described to be deregulated in both individuals who experienced early psychosocial stress and in patients with a wide range of psychiatric disorders. The NR3C1 gene codes for the glucocorticoid receptor, a key element involved in several steps of HPA axis modulation. In this review, we gather existing evidence linking NR3C1 methylation pattern with either ELS or psychopathology. We summarize that several types of ELS have been frequently associated with NR3C1 hypermethylation whereas hypomethylation has been continuously found to be associated with post-traumatic stress disorder. In light of the reported findings, the main concerns of ongoing research in this field are the lack of methodological consensus and selection of CpG sites. Further studies should target individual CpG site methylation assessment focusing in biologically relevant areas such as transcription factor binding regions whereas widening the examined sequence in order to include all non-coding first exons of the NR3C1 gene in the analysis.
Introduction
Mental disorders affect around one third of Europe's population and cause the greatest effect in terms of disability-adjusted life-years (DALYs) (Kaplan and Laing, 2004) . Anxious-depressive disorders have particularly high prevalence ratios as well as the highest associated risk of suicide (for a review, see Miret et al., 2013) . The lifetime prevalence of major depression disorders (MDD) ranges from 1% to 29.9% depending on biological, geographical and sociocultural variables (Kessler and Bromet, 2013; Kessler et al., 2012) . The lifetime prevalence for anxiety disorders is around 30% and its lifetime morbid risk is estimated to be as much as 41.7% in the US (Kessler et al., 2012) .
In contrast, although post-traumatic stress disorder (PTSD) has a moderately low prevalence in developed countries (around 1%), its incidence increases dramatically in subjects exposed to a number of severe traumatic experiences (for a review, see Keane et al., 2006) . Indeed, PTSD patients must have experienced recent severe trauma in order to meet the recent DSM5 criteria (American Psychiatric Association, 2013) . Finally, borderline personality disorder (BPD) affects 0.5-5% of the general population; many authors have reported its association with childhood maltreatment, especially sexual abuse (Leichsenring et al., 2011) .
Epidemiological studies have reported that psychosocially stressful events are a necessary triggering factor for the adult onset of an extremely high percentage of the aforementioned mental disorders, which can be referred as "stress-related disorders" (for a review, see Slavich et al., 2010) . Of particular interest is the extensive scientific literature on the major causal role of early adversity in the sensitization to adult psychopathology, with special emphasis on the impact of childhood maltreatment on vulnerability to stress-related disorders in adulthood (for reviews of this topic, see Carr et al., 2013; Strüber et al., 2014; Teicher et al., 2003) .
Childhood maltreatment prevalence ratios are estimated to be as high as anything from 4% right up to 16% in developed countries, depending on the type of abuse (Gilbert et al., 2009) ; it thus constitutes a major health concern in developed societies.
The long latency between early exposure to environmental risk factors and the late onset of a pathological status is widely observed in several complex disorders such as cancer, metabolic diseases and psychiatric conditions. Early life events, such as prenatal stress or childhood adversity, have the potential to modify later vulnerability to complex disorders due to developmental plasticity, i.e., the ability to develop in various ways depending on the early environment allows organisms to adapt. This evolutionary competence is probably mediated at least in part by epigenetic mechanisms such as histone modifications and DNA methylation (Gluckman et al., 2008; Petronis, 2010; Ptak and Petronis, 2010) .
The hippocampus is a brain area that is crucial in the modulation of the hypothalamic-pituitary-adrenal (HPA) axis: our primary stress response system. Alterations in both hippocampal volume and functionality have been associated with psychiatric disorders, especially with major depression (Anacker et al., 2011) . Indeed, prenatal and childhood trauma can modulate the HPA axis (Ehlert, 2013) . Briefly, upon exposure to stress, the paraventricular nucleus of the hypothalamus activates and secretes corticotropin-releasing hormone (CRH) which promotes the release of adrenocorticotropic hormone (ACTH) from the anterior pituitary to the adrenal glands, which finally release glucocorticoids. In humans, cortisol distributes systemically and executes a wide range of functions involving the immune, digestive and endocrine systems, including HPA axis self-regulation. As a lipophilic molecule, cortisol crosses the cellular membrane by passive diffusion and binds to the cytoplasmic mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). MR has a higher affinity for glucocorticoids than GR; thus, GR activation is key for an individual to appropriately cope with stress.
Once bound to cortisol, GR can translocate to the nucleus, where it acts both as a transcription factor and as a repressor. This coupling enables the dissociation of a chaperone complex, which is preventing nuclear translocation of GR in the absence of glucocorticoids. Interestingly, both epigenetic modifications and genetic variability of a certain co-chaperone of this complex, FKBP5, have been associated with stress-related disorders, specifically PTSD (Binder, 2009; Klengel et al., 2013) .
The human glucocorticoid receptor is encoded by the NR3C1 gene, spanning almost one half mega base pairs of chromosome 5. It contains 17 exons, nine of them are non-coding exons located at the gene promoter (Fig. 1) . Seven of these non-coding exons are clustered along the same CpG island (see Fig. 2 for the complete sequence).
A decade ago, Weaver et al. (2004) successfully found in rodents an epigenetic modification of the NR3C1 gene that was indicative of differential maternal rearing behavior. Specifically, rat pups raised by mothers that exhibited more nursing behavior exhibited remarkable hypomethylation at a specific CpG site located at an NGFI-A binding site; which suggested it was involved in transcription modulation.
Based on prior evidence from animal studies, over the last decade, a significant number of authors have focused their research on the epigenetic modulation of the NR3C1 gene in humans in association with early stress, as well as with additional variables such as stress reactivity and different psychopathological conditions. DNA methylation has been explored in a myriad of tissues and clinical profiles, including both peripheral tissues (blood and saliva) and central nervous system samples from patients as well as controls.
Nevertheless, many concerns regarding particular epigenetic modifications of the NR3C1 gene, the relevance and nature of early stressors and the specific clinical profile associated with these variables, remain to be elucidated.
Within this framework, the main goals of this review are: (i) to ascertain which methodology should be used to assess DNA methylation in the NR3C1 gene; (ii) to determine which CpG sites within the NR3C1 gene are definitely relevant for the etiology of stress-related disorders, according to published data; and (iii) to discuss the rationale driving current research on this topic in order to address future analysis of subjects suffering from stress-related disorders. Fig. 1 . NR3C1 gene structure. The NR3C1 gene consists of eight coding exons numbered 2-9 and nine non-coding first exons referred to as A-J (excluding "G") which are thought to act as alternate promoters. Exons 1D, 1J, 1E, 1B, 1F, 1C and 1H are located within a CpG island spanning 3 kb along the proximal promoter region of NR3C1 gene. The disarrayed numbering is due to the staggered discovery of the exons, which occurred at three different times. CpG dinucleotides with differential methylation may be located all along the NR3C1 gene sequence but epigenetic research focuses on the only CpG island described in this gene, which is located at a promoter region.
Methodology

Selection criteria
Research was conducted via a systematic literature search in the PubMed, PsycINFO and Web of Science databases. The search terms were the following: "NR3C1 or glucocorticoid receptor", "methylation" and "stress or childhood adversity or childhood abuse or maternal disorder". The English language filter was activated, which excluded 3 of the 103 papers that the defined search retrieved. We then excluded from the resulting pool: all papers reporting research on animals (n = 37); and papers which did not report original research (n = 30). To be considered suitable for the present review, the papers needed to include either an early or a late stress measure in association with a thorough methylation assessment of a CpG island located at the NR3C1 gene promoter (Figs. 1 and 2) . The final set consisted of 23 papers to be reviewed (Table 1) .
Brief introduction to the assessment instruments and scales for measuring psychopathology and experienced adversity
Psychiatric diagnoses need to rely on instruments and scales that measure symptoms, since there is no known biomarker for any mental disorder. The Diagnostic and Statistical Manual of Mental Disorders (DSM) contains the reference criteria for diagnosing psychiatric conditions and it is widely used in both health care and research. Additionally, there is a number of scales designed for characterize specific disorders and/or target populations, which have been utilized in the studies analyzed in this review such as: (i) Edinburgh Depression Scale (EDS); (ii) Hamilton rating scale for anxiety (HAM-A); (iii) Hamilton rating scale for depression (HAM-D); and (iv) Pregnancy Related Anxiety Questionnaire (PRAQ). Early life stress (ELS) can be also measured by a number of scales. The Childhood Trauma Questionnaire (CTQ) is a validated instrument commonly used for research purposes which measures five types of childhood adversity: physical, sexual and emotional abuse and physical and emotional neglect. Papers reviewed include several measures of early adversity such as the Childhood Trauma Interview (CTI), the Early Trauma Inventory -Self Report (ETI-SR) and the Childhood Experience of Care and Abuse (CECA), among others.
Prenatal stress measures can be derived from Obstetrical Complications (OCs). None of the articles reviewed herein included a comprehensive examination of OCs but of specific maternal conditions that may be deleterious for fetal growth and adequate development such as mood disorders experienced during pregnancy and pre-eclampsia.
Finally, stress reactivity can be quantified by means of several challenges such as: (i) the Trier Social Stress Test (TSST), where cortisol levels are monitored in subjects exposed to psychosocially stressful situations; (ii) the dexamethasone suppression test (DST), where subjects are administered with a synthetic glucocorticoid, dexamethasone, in order to measure HPA axis functioning; and (iii) the combined dexamethasone/CRH (dex/CRH) challenge, where following dexamethasone administration, subjects also receive a CRH dose for a more sensitive measure of HPA axis activity.
NR3C1 gene and CpG island structure
The NR3C1 gene codes for the glucocorticoid receptor and is located in the reverse strand of chromosome 5q31. It has 16 splice variants, 3 isoforms which are derived from 3 splicing (GR-␣, GR-␤ and GR-P) and 8 coding exons plus 9 alternate non-coding first exons which can be transcribed to the mRNA level but are not translated to any known protein. The first exons have different expression ratios along with distinct tissue distributions and their function remains widely unknown. In the 5 untranslated region of the NR3C1 gene, there is a CpG island spanning 3 kb located at chr5:142,782,071-142,785,071 (GRCh17/hg19 assembly) which includes seven of the aforementioned nine first exons: 1 D , 1 J , 1 E , 1 B , 1 F , 1 C (which has three splice variants) and 1 H . A schematic view of NR3C1 gene structure can be seen in Fig. 1 . In addition, a detailed view of the whole sequence of this CpG island is depicted in Fig. 2 , where all of its individual CpG sites have been highlighted. NGFI-A binding sites within exon 1 F promoter are emphasized with red boxes as they constitute the main reported findings across the literature in both humans and rats. Table 1 summarizes the sample description, tissues analyzed, methodology used to assess DNA methylation, targeted regions of the NR3C1 gene and stress variables considered in the 23 papers eligible for this review, along with their main findings. 21 papers analyzed some sort of ELS: 8 of them focused on prenatal stress, 12 examined childhood and/or adolescent trauma, while one additional paper took into account both prenatal stress and childhood adversity. Thirteen of the studies were performed on healthy subjects, while the remaining ten examined several psychiatric disorders including major depressive disorder (MDD), post-traumatic stress disorder (PTSD), borderline personality disorder (BPD), bulimia nervosa (BN) and suicide completion (SC). The samples analyzed included post-mortem brain tissue (n = 2), saliva (n = 4), cord blood and placenta (n = 7) and peripheral blood (n = 10), while one of the studies specifically examined T cells.
Results and discussion
Variables assessed by papers reviewed
NR3C1 methylation, ELS and psychopathological condition
Seventeen of the 21 papers accounting for ELS found significant correlations between ELS exposure and DNA methylation at a number of CpG sites located at several of the alternate first exons of the NR3C1 gene. The findings are reported below, sorted by region. The paradigmatic region encompassing exon and promoter 1 F will be the first to be reviewed.
NR3C1 gene -1 F region
The region 1 F (including both promoter and exon) contains 47 CpG sites; 25 of them have been reported at least once as being differentially methylated. Although nearly all the research groups (20 out of 23) considered methylation of the NR3C1 region 1 F , not all of them analyzed the same section ( Table 2 ). As shown in Fig. 3 , most researchers included the region immediately anterior to exon 1 F in their analyses; this genomic locus is particularly intriguing since it contains the NGFI-A binding region which was reported to be epigenetically modified by Weaver et al. (2004) . Accordingly, methylation of this promoter region (comprising CpG sites from 35 to 37) has regularly been associated with both ELS and psychopathological condition.
3.2.1.1. 1 F region -CpG 35. CpG site 35 (also referred to as 1 F CpG 1 or F13 depending on the study) has been reported to be differentially methylated by five research groups in association with several phenotypes: (i) prenatal stress as measured by maternal anxious-depressed condition during pregnancy (Hompes et al., 2013; Oberlander et al., 2008) ; (ii) early parental loss and low levels of parental care (Melas et al., 2013; Tyrka et al., 2012) ; and (iii) childhood maltreatment (Weder et al., 2014) . Hypermethylation was always associated with early stress exposure, with the exception of the results of Weder et al., who did not report the direction of the effect.
3.2.1.2. 1 F region -CpG 36. 1 F CpG 36 (also referred to as 1 F CpG 2 or F12) newborn hypermethylation has been associated with maternal psychopathology during pregnancy in three separate studies, as assessed by clinical records of depression diagnosis, EDS, HAM-A, HAM-D and PRAQ fear of delivery and fear of integrity scores (Conradt et al., 2013; Hompes et al., 2013; Oberlander et al., 2008) .
3.2.1.3. 1 F region -CpG 37. 1 F CpG 37 (also referred to as 1 F CpG 3 or F11) methylation has been associated with both ELS and psychopathology in humans by six distinct research groups. It corresponds to the paradigmatic CpG dinucleotide reported by Weaver et al. (2004) to be strikingly hypomethylated in rats which received higher maternal care as pups. Increased 1 F CpG 37 newborn methylation has been associated with maternal EDS and HAM-D scores during pregnancy (Oberlander et al., 2008) . Similarly, early parental loss and childhood maltreatment were associated with hypermethylation at this CpG site in healthy adults (Romens et al., 2014; Tyrka et al., 2012) . Finally, 1 F CpG 37 methylation was found to be decreased in PTSD subjects who exhibited higher severity of intrusive memories (Vukojevic et al., 2014) , and in newborns either formerly exposed to maternal smoking during pregnancy (Stroud et al., 2014) or to a maternal anxious-depressed condition during pregnancy, as measured by EDS and PRAQ fear of integrity scores Table 2 Main epigenetic findings in the region 1F.
Region 1F
Main findings 1-29 Isolated associations between methylation at particular CpG sites and early psychosocial stress (see Table S3 for further detail).
30-32
Putative NGFI-A binding region. Increased methylation at this region was associated with both prenatal stress and childhood abuse in three independent studies. One additional study reported decreased methylation in association with prenatal stress (see Table S1 for further detail).
33-34
Methylation at CpG sites 33 and 34 was not reported as associated with any stress or clinical variable in any of the papers reviewed.
35-38
NGFI-A binding region. CpG site 37 is homologous to rat's CpG site 16 as identified by Weaver et al. (2004) to be differentially methylated according to maternal behavior. Methylation at CpG sites 35-37 positively correlates to early stress exposure, as reported by six independent research groups. One additional study reported this association to be negative when analyzing a CpG unit which included CpG sites 37 and 38. Methylation negatively correlated to PTSD severity.
39-47
Methylation at this region positively correlates to early stress exposure as experienced either prenatally or during childhood. Altered methylation at CpG sites 40-47 has been reported in BPD samples (see Table S2 for further detail). ( Hompes et al., 2013) . CpG 37 methylation will be discussed below in association with secondary variables. Remarkably, the results reported by Hompes et al. (2013) refer to the CpG units F12.13 and F10.11, which include CpG sites 35 and 36, and CpG sites 37 and 38, respectively.
3.2.1.4. 1 F region -CpG sites from 30 to 32. A second cluster of differentially methylated CpG sites consists of the CpG dinucleotides from 30 to 32 which are located at a putative non-canonical NGFI-A binding site (McGowan et al., 2009) . Findings in this region are not always reported as CpG-specific but map to a small cluster of CpG dinucleotides (Table S1 ). Three out of four papers found higher levels of methylation in this region associated with either childhood abuse or prenatal stress.
3.2.1.5. 1 F region -CpG sites from 39 to 47. Thirdly, a region spanning CpG sites 39-47, which are located in the exonic 1 F sequence and beyond (toward the 1 C promoter), has also been widely reported as associated with several early stressor and psychopathological outcomes by a number of authors (Table S2) . Two separate groups found associations between average methylation and either childhood maltreatment (Perroud et al., 2011) or clinical severity (Martín-Blanco et al., 2014) in BPD samples in a region encompassing 1 F CpG sites 40-47. One study reported significantly higher methylation percentages in a region spanning 1 F CpG sites 30-39 (Radtke et al., 2011) . Tyrka et al. (2012) found a high intercorrelation between methylation at CpG sites from 41 to 47; that is to say, methylation at these CpG sites fluctuate in a coordinated fashion.
3.2.1.6. Prior 1 F regions -CpG sites 1-29. CpG-specific methylation findings in the region spanning CpG sites 1-29 are scarce (Table S3) .
Globally, increased methylation has been associated with several measures of early stress (Hompes et al., 2013; Van der Knaap et al., 2014) .
Intriguingly, Edelman et al. found CpG site 12 to be differentially methylated in males and females; while its methylation was a significant predictor of cortisol output after the Trier Social Stress Test (TSST) only in females (Table 3) , as discussed below in Section 3.4. These results may point to gender-specific regulation of the HPA axis driven by subtle epigenetic differences in the NR3C1 gene. Accordingly, males and females respond very differently to a stress challenge (Edelman et al., 2012) . Differential modulation of the stress response in males and females may be involved in the large dependence of the prevalence of psychiatric illnesses on gender.
PTSD continues to be associated with hypomethylation (Yehuda et al., 2014) . CpG sites 12 and 13 are of special interest since they constitute a non-canonical NGFI-A binding site (McGowan et al., 2009 ).
3.2.1.7. Mean methylation of other 1 F subregions. Specific CpG data were not available in four papers that assessed 1 F methylation (Edelman et al., 2012; Mulligan et al., 2012; Radtke et al., 2011; Van der Knaap et al., 2014) : the experience of ELS-such as maternal exposure to intimate partner violence (Radtke et al., 2011) , war stress (Mulligan et al., 2012) during pregnancy or childhood experiences of sexual abuse (Van der Knaap et al., 2014)-was associated with average hypermethylation of 1 F regions (see Fig. 3 for a detailed description of assayed 1 F regions by paper). Furthermore, Perroud et al. (2011) performed most of their statistical analysis in relation to the mean methylation value and found associations between 1 F hypermethylation and both the severity and frequency of different types of childhood maltreatment (specially Table 3 Correlations between peripheral cortisol measurements in either basal or stress-related conditions and NR3C1 methylation.
Study Methodology Findings
Oberlander et al.
Saliva samples were collected at baseline and at post stress recovery following a stress challenge Greater methylation at 1F CpG 37 associates with greater HPA reactivity (increasing cortisol after the stress challenge) De Rooij et al. (2012) a Saliva samples were collected at 5 and 20 min during baseline, and in five occasions following several steps of a psychological stress protocol 1C exon methylation was positively associated with stress reactivity cortisol levels (peak) and self-perceived stress variables: perceived performance and control. It was negatively associated with perceived stress. Tyrka et al. (2012) Dex Only for women, average methylation of 1F promoter (CpG sites 1-39) negatively correlated to salivary cortisol after the TSST Labonté et al. (2014) Basal cortisol levels were measured across daytime Cortisol levels were lower in the PTSD group, and 1B CpG-specific methylation positively correlated to cortisol levels Weder et al., 2014 Basal cortisol levels were measured in the morning CpG sites 1F 39 and 1C 11 predicted morning cortisol value Yehuda et al. (2014) DEX Suppression Test (DST) and 24-h urine collection PTSD subjects exhibited a hypersuppression after DST together with lower urinary cortisol excretion; 1F methylation negatively correlated to cortisol decline Perroud et al. (2014) Basal cortisol levels were measured in the morning Exposed mothers and their children exhibited lower cortisol levels; 1F methylation negatively correlated to cortisol levels Stroud et al. (2014) Cortisol stress response was elicited using the NICU Network Neurobehavioral Scale (NNNS) MSDP-exposed children exhibited attenuated baseline cortisol and cortisol reactivity together with 1F CpG 37 decreased methylation a Significance fades when adjusting for sex, educational level, smoking and physical activity suggesting that these variables may be driving methylation differences or stress reactivity outcomes.
sexual abuse and physical neglect). Additionally, Yehuda et al. (2014) reported mean hypomethylation of 1 F promoter in PTSD subjects. In contrast to the findings reviewed above, Steiger et al. (2013) found no associations between 1 F methylation and either BPD, history of suicidality or childhood abuse.
NR3C1 gene -1 B region
Two of the four studies that examined region 1 B methylation found no association with prenatal stress (Hompes et al., 2013) or either childhood abuse or clinical severity (Steiger et al., 2013) . Intriguingly, both the papers that did report associations between psychopathology (either suicide completion or PTSD) and DNA methylation were authored by Labonté et al. (2014 Labonté et al. ( , 2012 and cover a gene region placed immediately before exon 1 E , including its putative promoter and the whole exon 1 J . Labonté et al. (2014) showed a clear association between PTSD and overall hypomethylation of the 1 B promoter region. In contrast, when studying suicide completers with and without a history of childhood abuse, results are not so straightforward. Suicide completers exhibited CpGspecific hypermethylation at two CpG sites (one of them was found to be associated with decreased GR expression) and hypomethylation at a third CpG site when compared to controls, independently of history of childhood abuse (Labonté et al., 2012) . The CpG sites reported by the two studies do not match; even though exon 1 B is one of the most studied exons, there is no replication among studies.
NR3C1 gene -1 C region
Three of the four studies specifically examining promoter and region 1 C methylation were performed by the same research group (Labonté et al., 2014 (Labonté et al., , 2012 Steiger et al., 2013) and cover similar regions encompassing 59 CpG sites; 11 of them have been reported to be individually associated with either stress or psychiatric variables. Additionally, a second research group (De Rooij et al., 2012) analyzed a region specifically spanning exon 1 C (excluding its promoter region from the analysis). Steiger et al. (2013) found no epigenetic correlates of experiencing childhood abuse in BN subjects with or without BPD. Nevertheless, they did observe a set of differential CpG-specific hypermethylation patterns in both BN-BPD subjects when compared to controls without eating disorders, and in BN individuals with a history of suicidality when compared to controls. Labonté et al. (2012) identified four differentially methylated CpG sites in a suicide sample: one hypermethylated CpG site and one hypomethylated CpG site in suicide completers with a history of childhood abuse when compared to controls and non-abused suicide completers; and two hypermethylated CpG sites in suicide completers when compared to controls independently of history of childhood abuse. When examining PTSD subjects, significant global hypomethylation was revealed in a region encompassing 54 CpG sites in the exon 1 C promoter. Remarkably, one specific CpG site was found hypermethylated in PTSD patients (Labonté et al., 2014) . Among healthy individuals, De Rooij et al. (2012) described a positive association between 1 C mean methylation and levels of both education and physical activity; whereas methylation in this region negatively correlated to smoking. Additionally, a fifth study reported differential methylation at a specific CpG site (cg11152298) to be associated with childhood maltreatment. Nevertheless, this study did not report the direction of the effect and it is unknown whether early trauma is associated with hypermethylation or hypomethylation (Weder et al., 2014) . Once again, there is no replication among studies of region 1 C differential methylation.
NR3C1 gene -1 H region
Two of the studies that examined exon 1 H methylation analyzed a total of 69 CpG sites with a little overlap: just 6 CpG sites were examined by both. They reported mean hypomethylation values in either suicide completers with a history of childhood abuse (Labonté et al., 2012) or BN-BPD individuals (Steiger et al., 2013) compared to controls. Nevertheless, a third study extended the region analyzed beyond exon 1 H and reported higher methylation values in association with several measures of early trauma, such as repeated exposure to sexual and physical abuse or stressful life events experienced during adolescence (Van der Knaap et al., 2014) . The different methods used in prior studies preclude the replication of results.
3.2.5. NR3C1 gene -1 D region Hompes et al. (2013) found significant correlations between several measures of prenatal stress and levels of methylation at 10 CpG sites in exon 1 D (pertaining to 4 methylation units identified by MALDI-TOF) as measured in cord blood from newborns. Additionally, Van der Knaap et al. (2014) observed a significant negative correlation between repeated exposure to "other trauma" (non-sexual and non-physical) and overall methylation of a region spanning exon 1 D and beyond. Furthermore, Hogg et al. (2013) detected significant associations between methylation at CpG sites cg21702128, cg14558428, cg24026230 and cg13648501-which are located in the 1 D promoter-and early-onset pre-eclampsia (EOPE), together with higher mean methylation values at exon 1 D in EOPE subjects compared to controls. Lastly, Weder et al. (2014) also found differential methylation at CpG sites cg21702128 and cg13648501 in association with childhood maltreatment. Nevertheless, these associations lack the direction of the effect and it is unknown whether early trauma is associated with hypermethylation or hypomethylation. In this case, the 1 D CpG dinucleotides included in the Illumina BeadChip do not match those assessed by Hompes et al. or van der Knaap et al., which contributes to the lack of replicated results (the equivalence of the Illumina nomenclature and the CpG site numbering adopted in the current review is displayed in Table S4 ).
NR3C1 promoter methylation inversely correlates with GR expression
Six of the 23 papers reviewed explored GR expression coupled with epigenetic analysis (Hogg et al., 2013; Labonté et al., 2014 Labonté et al., , 2012 McGowan et al., 2009; Perroud et al., 2014; Vukojevic et al., 2014 ). Five of them described negative correlations between NR3C1 methylation at different first exons (including CpG sites in the 1 B , 1 C and 1 F exons) and GR expression (either total GR mRNA or specific GR transcripts) in both brain and peripheral tissues (T lymphocytes and saliva). Intriguingly, Labonté et al. (2012) reported a positive rather than negative association between 1 H methylation and expression which draws our attention back to Section 3.2.4, since 1 H methylation values were the only ones to be negatively associated with early stress.
Conversely, Hogg et al. (2013) did not find any relationship between NR3C1 methylation and expression. However, they did not assay 1 D containing transcripts but generic NR3C1 expression, which may have diluted moderate methylation changes of a scarcely expressed transcript. Nevertheless, there is no data on the expression of GR transcripts containing the 1 F exon in peripheral blood in relation to 1 F methylation.
NR3C1 methylation and stress reactivity
Nine of the 23 papers reviewed measured cortisol levels either at baseline or after a stress challenge-such as the Trier Social Stress Test (TSST) or the Dex/CRH challenge-in order to measure basal and stress-related HPA axis functioning. These studies produced inconsistent data (Table 3) . While five papers point to a positive association between methylation and cortisol levels, either at baseline or after a stress challenge (De Rooij et al., 2012; Labonté et al., 2014; Oberlander et al., 2008; Stroud et al., 2014; Yehuda et al., 2014) , three studies claim these associations to be negative (Edelman et al., 2012; Perroud et al., 2014; Tyrka et al., 2012) . Furthermore, methylation at two CpG sites as analyzed by Weder et al. (2014) were found to predict morning cortisol values but the direction of the effect is not reported. Controversial findings regarding cortisol measurements are in line with previous studies (for a review, see Strüber et al., 2014) .
Both hypermethylation and hypomethylation of the NR3C1 gene may be maladaptive
While hypermethylation at specific CpG sites has been linked to ELS (see Section 3.2), a global pattern of hypomethylation has been found in PTSD subjects. Intriguingly, depressed patients are widely reported to show non-suppression after the dex/CRH test (Heim et al., 2008) ; while individuals suffering from PTSD exhibit a hypersuppression after the DST (McFarlane et al., 2011) . This divergence suggests that the timing of the stress exposure could determine differential modulations of HPA axis functioning: (i) early adversity, such as prenatal stress or childhood maltreatment, increases methylation in promoter regions of the NR3C1 gene which dampens GR expression, promotes glucocorticoid resistance and may trigger several psychiatric disorders, such as a depressive episode or BPD in adulthood; (ii) late and acute exposure to trauma may induce demethylation in the same regions, thus increasing GR expression and leading to a sensitization of the HPA axis.
Alternatively, subjects with hypomethylation of the NR3C1 gene prior to trauma may suffer stress coping difficulties together with an increased recall of negative memories, thus becoming more susceptible to developing PTSD after being exposed to severe trauma during adulthood. In fact, Perroud et al. (2014) recently reported the percentage of methylation of the NR3C1 exon 1 F across a sample of genocide-exposed mothers and their children, thus providing methylation measures that can be associated with late stress. Intriguingly, the exposed mothers showed increased CpG-specific methylation compared to non-exposed mothers, which suggests stress-associated NR3C1 hypermethylation at any stage of life and further supports a role of basal hypomethylation prior to trauma in triggering PTSD.
Biological relevance of methylation at a NGFI-A binding site
Intriguingly, four papers reported separate biomarker-like features associated with exon 1 F CpG 37 methylation. As discussed in Section 3.4, Oberlander et al. (2008) reported an association between methylation at this particular CpG site and HPA axis responsiveness: infants with increased cortisol responses after a stress challenge had higher methylation. Meanwhile, Stroud et al. (2014) found CpG 37 methylation to be positively correlated with cortisol reactivity. Accordingly, Yehuda et al. (2014) found the same association in PTSD subjects whose CpG 37 methylation was lower and predicted cortisol levels after the DST. Subsequently, Vukojevic et al. (2014) investigated the putative interaction between NR3C1 methylation and memory performance during a fMRI picturerecognition task in healthy subjects; they found a correlation between CpG 37 methylation and brain activity related to the successful recognition of previously seen pictures in men but not in women. Strikingly, CpG 37 methylation was negatively correlated with the correct recognition of previously seen pictures in men.
Tissue distribution of alternative non-coding first exons
The tissue distribution of GR first exons has been extensively examined. In this regard, mRNA containing exons 1 B or 1 C in any of its splice variants (1 C1 -1 C3 ) constitute the most widely expressed NR3C1 transcripts as they are detected in the hippocampus, T cells, B cells, monocytes, heart muscle, lungs, liver and skin, among other tissues examined (Presul et al., 2007; Turner and Muller, 2005) . Moreover, mRNAs containing either 1 B or 1 C are the most abundant transcripts in several brain areas including the hippocampus . In contrast, exons 1 E and 1 J are the least abundant in brain, with marginal expression ratios accounting for 0.1% of total GR expression . Strikingly, intronic upstream regions preceding both the 1 E and 1 J exons do not exhibit promoter activity as opposed to the corresponding regions of the five remaining first exons located in the same CpG island (Cao-Lei et al., 2011) . Exons 1 D , 1 F and 1 H exhibit intermediate expression ratios. Exon 1 D has been reported to be expressed in brain and placenta (Hogg et al., 2013) ; exon 1 F is expressed in immune cells and brain (Turner and Muller, 2005) ; and exon 1 H has been found to be expressed in several tissues including liver, lung, heart muscle and a number of blood cell subpopulations (Turner and Muller, 2005) . Interestingly, the human hippocampus was the only tissue analyzed where all the non-coding exons are present at the mRNA level (Turner and Muller, 2005) .
Conclusions
This study is the first to systematically review all the scientific literature regarding NR3C1 non-coding first exon methylation in association with both psychosocial stress at several stages of life (including fetal development, early childhood, adolescence and adulthood) and a broad range of stress-related disorders. Even when accounting for moderate differences, early life adversity has been repeatedly shown to be associated with hypermethylation at several CpG sites located in the non-coding first exons of the NR3C1 gene. Such epigenetic modifications may impair HPA axis functioning and further predispose early stress-exposed subjects to a wide range of psychiatric conditions, such as major depression or borderline personality disorder, in adulthood. Taking into account all the findings discussed in this review, some methodological issues should be noted for further research (as summarized in Fig. 4 ).
How do we assess DNA methylation?
Our first concern regard the differences observed in the assessment of methylation across the various studies, which preclude meta-analysis. On the one hand, the methods used to measure methylation differed greatly between studies including: bisulfite pyrosequencing; cloning and further Sanger sequencing of regions of interest; the use of genome-wide methylation arrays; and mass spectrometry (MS) analyses. Because of the limited capacity of MS to discriminate between specific CpG dinucleotides, studies using MALDI-TOF tend to report average methylation values in minor sets spanning two or more individual CpG sites, rather than CpG-specific results (Hompes et al., 2013; Melas et al., 2013; Van der Knaap et al., 2014) . This methodological discrepancy could be the primary cause of the apparently controversial findings of two separate research groups focusing on the same 1 F region while analyzing almost identical prenatal stress variables (Hompes et al., 2013; Oberlander et al., 2008) ; as discussed in Section 3.2.1. Their opposing findings also correspond to different stages of pregnancy, which may have contributed to the heterogeneity of the results. However, the results reported by Hompes et al. correspond to a CpG unit including CpG sites 37 and 38; thus, CpG 37 methylation could be masked by a marked hypomethylation of CpG 38.
On the other hand, regardless of the method selected, while some authors reported average methylation of assayed regions, others displayed their data in a CpG by CpG fashion, while a third group reported both measures of methylation. The authors reporting both types of data reveal the seeming biological relevance of assaying methylation in a CpG-specific manner. For instance, McGowan et al. (2009) detected a higher global methylation percentage in abused suicide victims than in either controls or non-abused suicide victims. Strikingly, when examining individual CpG sites, it seems that this overall difference is mainly driven by two out of 38 assayed CpG sites (CpG sites 30 and 32). Thus, mean methylation differences could be driven by a very few truly informative CpG sites placed in biologically relevant positions, such as transcription factor binding sites, such as, the widely reported nerve growth factor-inducible protein A (NGFI-A) binding site in both rats (Weaver et al., 2004) and humans (McGowan et al., 2009) .
However, once the specific methylation value is available, the statistical approach is still challenging. There a number of confounders which may directly influence methylation, mainly (i) genetic variability in the DNA methylation machinery genes, and (ii) genetic variability affecting the epigenetically regulated region of interest. Genetic variability in epigenetic machinery genes has been widely studied regarding psychiatric disorders (Murgatroyd and Spengler, 2012) and genetic variation of a DNA methyltransferase (DNMT3B) has been associated with environmental sensitivity affecting cognitive plasticity (Córdova-Palomera et al., 2015) . In this regard, genetic variation directly affecting CpG sites will modify methylation percentage as these regions will be unable to be chemically modified to incorporate a methyl group. Nevertheless, there are almost no described SNPs overlapping with CpG sites of interest at the NR3C1 gene and, when present, they display very low minor allele frequencies (such as rs562481368 or rs573565118, both located at region 1F, overlapping with CpG sites 39 and 46 respectively).
Where do we look?
Secondly, there is no agreement regarding the delimitation of NR3C1 first exon promoter regions. This could be the reason why authors who allegedly focus on the same exons have actually analyzed distinct CpG sites. This may be due to late annotations of exons 1 D -1 J compared to the initial report of exons 1 A -1 C , which lead to several misconceptions regarding the topic. In fact, another controversial issue is whether to explore promoter or exonic regions; or both. Most of the papers reviewed rely on epigenetic findings reported in rats (Weaver et al., 2004) and consequently concentrate on human exon 1 F and its associated promoter. Hence, region 1 F should be further analyzed as this exon may be key for the modulation of stress responses. Furthermore, some authors examined wider regions according to expression studies in brain tissue . Exons 1 B and 1 C should be examined in detail since they are the most expressed NR3C1 first exons throughout the body, including the brain. Intriguingly, findings reported for these exons-although limited-seem to be associated with final psychopathological phenotype (either suicide completion or PTSD) rather than with any early life stressor; which further suggests a possible role as biomarkers.
Moreover, the region 1 E emerges as an elusive target. Although it has not been directly addressed by any research group, Labonté et al. examined its putative promoter methylation, while theoretically focusing on the 1 B promoter. Recently, Cao-Lei et al. (2011) examined all the intronic regions immediately upstream of exons 1 B -1 F plus 1 H and 1 J and reported promoter activity for all of them except those preceding exons 1 E and 1 J . Further studies need to be performed on the 1 J/E region in order to determine whether epigenetic modifications have the potential to modulate the expression of the least abundant first exons of the NR3C1 gene; and whether such variations have any functional repercussion on GR activity and further HPA dysregulation. As they are the least expressed exons, they could promote the transcription of the least abundant isoform of the glucocorticoid receptor: GR-␤, whose function and relevance are still largely unknown, but which seems to antagonize GR-␣ thereby promoting glucocorticoid resistance Webster et al., 2001) . Interestingly, transcripts containing exon 1 E have been reported to be expressed in immune cells, particularly in monocytes and CD8+ T cells (Turner and Muller, 2005) . Indeed, a decreased GR␣/GR␤ expression ratio has been identified in monocytes from MDD patients, which suggests a further role of NR3C1 modulation in ongoing psychopathological status Fig. 4 . Box diagram representing the main findings reported and suggested future directions to improve our knowledge of the role of early life stress upon NR3C1 methylation and psychopathological outcomes. The NR3C1 gene contains a CpG island which encloses non-coding alternate first exons 1D-1J spanning 3 kb. This CpG island consists of around 300 CpG sites, i.e., 300 methylation-sensitive loci. (Carvalho et al., 2014) . There is much literature regarding the complex interplay between the HPA axis and immune system, e.g., the janus-faced actions of glucocorticoids on the modulation of inflammatory response (Sorrells et al., 2009) , as well as the putative engagement of inflammation in the etiology of psychiatric disorders (Haroon et al., 2012) . Cortisol can act as an anti-inflammatory molecule by means of peripheral GR located in immune cells, which should encourage future research to focus on the study of the epigenetic signature of exon 1 E in peripheral samples, as it may be involved in the neuroendocrine modulation of inflammation.
In addition, exons 1 D and 1 H need to be studied further since the evidence regarding their association with early stress is very limited. These exons reach transcription rates comparable to those of exon 1 F . Finally, a certain pool of CpG sites remains unexplored. Although they are placed within the CpG island containing exons 1 B -1 F , 1 H and 1 J , they have not been targeted by any study to date (Fig. 4) .
Furthermore, researchers in this field do not only need to choose carefully which exons-and which CpG sites along with them-should be analyzed, but also in which tissues. As exemplified in several reviews but particularly in the current one, epigenetic research has been conducted on a number of tissues including postmortem brain samples together with peripheral tissues such as saliva and blood. Epigenetic signatures are known to differ from one tissue to another; nevertheless, recent studies encourage the common assumption of epigenetic hallmarks in blood being replicable in brain tissues (Ewald et al., 2014; Masliah et al., 2013) .
Finally, it is important to keep in mind that DNA methylation does not operate on its own but in conjunction with a number of additional epigenetic mechanisms such as histone modification and microRNA-mediated gene silencing. While there is no research yet regarding the role of histone modifications in NR3C1 regulation, microRNAs are gaining popularity and will be studied extensively in the next decade. As proposed by Turner et al. (2010) in a previous review, microRNAs may play an essential role in regulating translation of GR. Recently, several authors have suggested the role of microRNAs in either the regulation of a GR-dependent signaling network (Vallès et al., 2014) or the development of glucocorticoid resistance after exposure to chronic stress (Jung et al., 2015) . Interestingly, it has been also described that expression of a specific microRNA (miR-137, which is a hit of a GWAS for schizophrenia) can be regulated by methylation in adult neural stem cells from mice (Szulwach et al., 2010) thus illustrating the crosstalk between distinct epigenetic marks in neural tissue.
Why do we analyze NR3C1 methylation?
Identifying epigenetic signatures associated with early stress or psychopathology does not imply causality. A limited number of papers examine mRNA expression in relation to epigenetic modifications (Hogg et al., 2013; Labonté et al., 2014 Labonté et al., , 2012 McGowan et al., 2009; Perroud et al., 2014; Vukojevic et al., 2014) . Such research is essential in order to establish functional correlations between methylation patterns and phenotypic variation. The expression studies reviewed here were performed in either brain tissue, saliva or blood samples. Notably, five of the six studies that assessed expression together with methylation reported an inverse association between the aforementioned variables. Further studies examining both DNA methylation and gene expression are needed to elucidate the functional repercussions of epigenetic modifications of the exon 1 F in relation to ELS.
There is still a major concern regarding the extent of the reported methylation differences (Table 1) . DNA methylation is an absolute modification: a CpG site is either methylated or unmethylated. Accordingly, methylation percentages ranging from 0% to 100% indicate uneven methylation across different cells. It is worth noting that most of the reported significant differences included in this review are values either under 5% or merely not specified (nor suitable to be extrapolated from figures). This may raise three concerns: (i) between-group differences of 5% are certainly close to the detection sensitivity limits of the methylation assessment techniques employed (Klengel et al., 2014) ; (ii) these small changes are likely to be caused by marginal cellular subsets (accounting for a tiny fraction of the total cell population), which may have been differentially methylated after a stressor; and (iii) since the link between DNA methylation and gene expression is relatively continuous (Siegfried and Simon, 2010) , these minor methylation differences may induce only relatively small transcriptional changes.
Nevertheless, several reports have consistently found this CpG island to be widely unmethylated with average methylation levels below 5% suggesting that small methylation increases in crucial CpG sites may have the potential to influence transcription greatly. In this regard, it is worth mentioning that some novel statistical approaches to analyze DNA methylation changes between groups, with a special emphasis on large methylation differences, have been able to retrieve biologically-feasible results (Dempster et al., 2014) and may thus be useful in this context. These moderate methylation differences could be due to differential methylation patterns across distinct cell types. Both blood and brain samples comprise a number of separate cell types such as monocytes, T-lymphocytes and B-lymphocytes, and neurons, astrocytes and microglia, respectively. Focusing on epigenetic signatures of specific cell types rather than measuring methylation in mixed tissues may elucidate not only which genes are deregulated in pathological conditions but also which cell types are more vulnerable to stress and thus involved in the etiology of these disorders.
Future directions
All of the foregoing should be taken into account in future studies that examine the methylation of the NR3C1 gene promoter region. Likewise, the exons to be studied should be selected in accordance with transcriptional studies, providing mRNA expression and tissue distribution data in order to focus on regions that are biologically relevant for HPA axis functioning. In this regard, exon 1 F showed a significantly lower expression in the hippocampi of MDD subjects than in controls; which suggests its involvement in the etiology of mood disorders . Future selection of the CpG sites to be analyzed should prioritize those located in transcription factor (TF) binding regions, since methylation can prevent TF binding and thus impair gene expression. Additionally, specific cell types are more likely to exhibit homogenous epigenetic signatures rather than mixtures such as peripheral blood or brain homogenate.
With regard to study design, it would be very informative to analyze several variables simultaneously. Some such suggestions are: (i) to study both prenatal and childhood stress in order to assess whether they have additive or synergistic effects on NR3C1 methylation; (ii) to collect lifestyle information such as drug exposure, smoking habits and other factors known to modify epigenetic signatures as they can confound the results; (iii) to assess immune function by means of cytokine determination in plasma, to determine the extent to which psychosocial stress-induced epigenetic modifications of the NR3C1 gene can modulate the inflammatory response; and (iv) to study monozygotic twins discordant for either ELS or psychopathology in order to rule out heterogeneity due to genetic variability and non-shared environment.
